Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T-Lymphocytopenia”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Large-scale testing (Phase 3)WithdrawnNCT07492875
What this trial is testing

Study of Nogapendekin Alfa Inbakicept and iNKT Cells in Critically Ill Adults With Severe Community-Acquired Pneumonia

Who this might be right for
Community-Acquired Pneumonia (CAP)Acute Respiratory Distress Syndrome (ARDS)Sepsis+2 more
ImmunityBio, Inc.
Early research (Phase 1)Ended earlyNCT02664363
What this trial is testing

EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma

Who this might be right for
GlioblastomaGliosarcoma
Daniel Landi 3
Not applicableStudy completedNCT00001319
What this trial is testing

Evaluation of HIV-Negative Patients With Low CD4+ T Lymphocyte Counts

Who this might be right for
CD4 LymphocytopeniaIdiopathic CD4 Positive T Lymphocytopenia
National Institute of Allergy and Infectious Diseases (NIAID) 100
Not applicableStudy completedNCT02113930
What this trial is testing

Idiopathic CD4 Lymphocytopenia

Who this might be right for
Idiopathic CD4 Lymphocytopenia
Assistance Publique - Hôpitaux de Paris 47
Not applicableNot Yet RecruitingNCT07704281
What this trial is testing

Follow-up of the Cohort of Newborns Screened at Birth Using TREC Analysis

Who this might be right for
Severe Combined Immunodeficiencies (SCID)
Nantes University Hospital 450
Not applicableStudy completedNCT03549546
What this trial is testing

Expression of the Inhibitory Receptors on Lymphocytes T Cells After Lung Cancer Surgery.

Who this might be right for
Lung CancerSurgery
Centre Hospitalier Universitaire de Saint Etienne 31
Not applicableLooking for participantsNCT00867269
What this trial is testing

Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia

Who this might be right for
Idiopathic CD4+ LymphocytopeniaCryptococcal MeningitisWarts
National Institute of Allergy and Infectious Diseases (NIAID) 950
Testing effectiveness (Phase 2)Looking for participantsNCT02015013
What this trial is testing

Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Who this might be right for
Idiopathic CD4-PositiveT-Lymphocytopenia
National Institute of Allergy and Infectious Diseases (NIAID) 40
Not applicableStudy completedNCT07291986
What this trial is testing

To Compare the Clinical Outcomes of FemtoLASIK and ICL Implantation in Treating Moderate Myopia Focusing on Refractive Stability, Contrast Sensitivity and High Order Aberrations.

Who this might be right for
Myopia, Moderate
Walid Osama Abdel Rahman Nour El Din 60
Not applicableStudy completedNCT01306188
What this trial is testing

Prognostic Value of Divpenia and CD4 Count in Relapsed Breast or Lung Cancer Patients

Who this might be right for
Breast CancerLung Cancer
Centre Leon Berard 179
Testing effectiveness (Phase 2)Temporarily pausedNCT03312244
What this trial is testing

Pyridostigmine as Immunomodulator in People Living With HIV

Who this might be right for
HIV-1-infectionCD4+ T LymphocytopeniaImmune Deficiency+1 more
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 60
Early research (Phase 1)Study completedNCT00693095
What this trial is testing

Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer

Who this might be right for
Glioblastoma
John Sampson 23
Not applicableLooking for participantsNCT03394053
What this trial is testing

The Mechanistic Biology of Primary Immunodeficiency Disorders

Who this might be right for
Primary Immunodeficiency Disorders
National Institute of Allergy and Infectious Diseases (NIAID) 2,500
Not applicableUnknownNCT04121065
What this trial is testing

Role of ADA SNPs in Subjects With Relapsing Multiple Sclerosis (RMS)

Who this might be right for
Relapsing Multiple Sclerosis
Neuromed IRCCS 150
Early research (Phase 1)Study completedNCT00626483
What this trial is testing

Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia

Who this might be right for
Malignant Neoplasms Brain
Gary Archer Ph.D. 34
Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Testing effectiveness (Phase 2)Active Not RecruitingNCT03519464
What this trial is testing

Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytopenia

Who this might be right for
Idiopathic CD4 T Cell Lymphocytopenia
National Institute of Allergy and Infectious Diseases (NIAID) 54
Not applicableStudy completedNCT03158987
What this trial is testing

Regional Differences in Human Immunodeficiency Virus (HIV) Testing

Who this might be right for
HIV SeropositivityCD4+ T Lymphocytopenia
Jena University Hospital 999
Not applicableEnded earlyNCT04874818
What this trial is testing

CD8+ T-cell PET/CT Imaging in COVID-19 Patients

Who this might be right for
Lymphopenia Due to COVID-19T-cellPET Imaging
Radboud University Medical Center 5
Testing effectiveness (Phase 2)Study completedNCT04578210
What this trial is testing

Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or Lymphopenia

Who this might be right for
Corona Virus Infection
Instituto de Investigación Hospital Universitario La Paz 84
Next Page